ENDP • NASDAQ
Endo International PLC
$0.37
After Hours:
$0.37
(1.93%)+0.0071
Closed: Jun 24, 7:37:22 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityIE headquartered
Previous close
$0.39
Day range
$0.36 - $0.40
Year range
$0.28 - $7.07
Market cap
86.45M USD
Avg Volume
24.93M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Financial performance
Revenue
Net income
(USD)Mar 2022Y/Y change
Revenue
652.26M-9.15%
Operating expense
245.97M15.60%
Net income
-71.97M-273.33%
Earnings per share
0.66-9.59%
EBITDA
158.73M-51.42%
Effective tax rate
2.70%
Financial performance
Total assets
Total liabilities
(USD)Mar 2022Y/Y change
Cash and short-term investments
1.41B-1.02%
Total assets
8.45B-8.52%
Total liabilities
9.76B-0.76%
Total equity
-1.31B
Shares outstanding
235.11M
Price to book
-0.07
Return on assets
4.22%
Return on capital
5.22%
Financial performance
Net change in cash
(USD)Mar 2022Y/Y change
Net income
-71.97M-273.33%
Cash from operations
201.32M-17.44%
Cash from investing
-48.84M-186.51%
Cash from financing
-189.20M-299.57%
Net change in cash
-36.39M-120.24%
Free cash flow
140.68M-46.92%
About
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system. Wikipedia
Founded
1997
Headquarters
Website
Employees
3,103
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for